ABSTRACT
Evergreening consists of multiple ways that pharmaceutical companies extend patent protection and prolong profitability of brand name drugs past patent expiration. In psychotropic medications, these strategies do not necessarily make more effective drugs, and often increase drug prices, which can result in lower access and utilization. There has not been a systematic literature review of evergreening strategies for psychiatric medications. Based on such a review, 11 strategies were identified and relevant examples were provided. Four case examples of commonly used psychiatric medications indicated evergreen prices 3 to 211 times the cost of the original medication, and the evergreen costs ranging from $132.00 to $10,125.24 higher than the original cost on an annual basis. The higher cost of evergreening medications can create inefficiencies and waste in healthcare resulting in lower-quality patient care. Healthcare providers, patient advocates, health insurance companies, and policy-makers should be aware of these practices to improve healthcare systems.
Subject(s)
Drug Costs , Insurance, Health , Humans , Psychotropic Drugs/therapeutic use , Pharmaceutical PreparationsABSTRACT
This article provides an overview of the clinical evaluation and clinical treatment on multiple levels of American Indian, Alaskan Native, Native Hawaiian, and Pacific Islander youth, and their families. Included are basic cultural beliefs and practices shared among multiple tribes and nations within this diaspora, where the most important concept is balance and harmony in healing. Readers are provided with current practice approaches to core issues of substance abuse, anxiety, depression, and suicidal ideation including case examples, psychopharmacology, and therapy.
Subject(s)
Native Hawaiian or Other Pacific Islander , Substance-Related Disorders , Adolescent , Humans , Substance-Related Disorders/diagnosis , Substance-Related Disorders/therapy , Suicidal IdeationABSTRACT
The objective of this study was to determine the longitudinal predictors of past-6-month suicide attempts for a diverse adolescent sample of Native Hawaiians, Pacific peoples, and Asian Americans. The study used longitudinal data from the Hawaiian High Schools Health Survey (N = 2,083, 9th to 11th graders, 1992-1993 and 1993-1994 school years). A stepwise multiple logistic regression was conducted. The final model consisted of three statistically significant predictors: (1) Time 1 suicide attempt, odds ratio = 30.6; (2) state anxiety, odds ratio = 4.9; and (3) parent expectations, odds ratio = 1.9. Past suicide attempt was by far the strongest predictor of future suicide attempts. Implications are discussed, including the need for screening of prior suicide attempts and focused interventions after suicide attempts.